ClinicalTrials.gg
Not yet recruitingNCT06379828Updated Apr 25, 2024

Self-assessment Tool for Implementing the ESCNH

An observational study in Development of a Tool to Assess the Level of Implementing the European Standards of Care for Newborn Health, Testing of the Developed Self-assessment Tool in European Hospitals and Self-Assessment, sponsored by Global Foundation for the Care of Newborn Infants. Not yet recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-25.

Sponsored by Global Foundation for the Care of Newborn Infants · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year 1 month ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to develop a tool for hospitals to self-assess the implementation of the European Standards of Care for Newborn Health (ESCNH), standards defining best-practice procedures for neonatal care. The tool shall support healthcare professionals across Europe to measure the level of implementation of the ESCNH, to identify variations in care delivery, and ultimately to improve neonatal care. To achieve this, healthcare professionals from all relevant backgrounds and parent representatives will be invited to take part in an electronic Delphi consensus approach. A subsequent pilot-testing among at least 10 hospitals across Europe will refine the developed tool, indicate potential errors, ensure user-friendliness, and improve the applicability.

Read the detailed description

This project aims to develop a uniformly applicable self-assessment tool in different languages with the overall goal to support care providers across Europe to measure the level of implementation of the ESCNH, to pinpoint possible inhibitors, and ultimately to increase the extent of implementation. Covering the great variety of standards in one hands-on and easy-to-use self-assessment tool requires prioritising the most important components. This has to be approached in a systematic and scientific manner. For this purpose, a two-round electronic (e) Delphi survey will be conducted followed by an expert workshop. The aim of the two-stage eDelphi process is to lay a solid ground for the self-assessment tool. Prior to the eDelphi rounds, members of the study team together with the Project Expert Group (PEG) will condense and prioritise the ESCNH into one online questionnaire and thereby elaborate the first framework of the self-assessment tool. Next to participant-related information such as profession or country of employment, the questionnaire will cover specific aspects of the eleven major topics of the ESCNH namely: Birth and transfer, medical care and clinical practice, care procedures, infant- and family-centred developmental care, neonatal intensive care unit (NICU) design, nutrition, ethical decision-making and palliative care, follow-up and continuing care, patient safety and hygiene practice, data collection and documentation, education and training. The questionnaire will subsequently, in the first eDelphi round, be evaluated by the eDelphi panel. The panel consist of approximately 100 healthcare professionals from various disciplines related to neonatal care as well as parent representatives. In the first eDelphi round, panellists will appraise the relevance of included content, the wording of questions as well as the prioritisation of content to be included in the self-assessment tool. This will be enabled through a predefined evaluation scheme as well as free-text fields. Based on feedback from panellists, the preliminary self-assessment tool will be adapted by adding additional information, removing unnecessary items and re-wording if necessary. In the subsequent (second) eDelphi round, the same panellists will receive qualitative and quantitative information on the adaptation of the first version and will have again the option to evaluate the adapted questionnaire. Remaining discrepancies will be discussed in a final consensus workshop. For this purpose, 20-30 panellists will be selected based on their level of experience and invited for participation. The result of the workshop will be the agreed-upon content for the self-assessment tool. Except for the workshop, data collection during the eDelphi rounds will be anonymous.

To ensure applicability, the self-assessment tool will be pilot tested in European hospitals. For this purpose, the self-assessment tool will be translated into 5 languages (German, French, Italian, Swedish, Portuguese, and Spanish). For the pilot-testing, healthcare professionals in 10 pilot hospitals across Europe will be invited to evaluate the self-assessment tool. Feedback of the pilot-testing will be discussed with the PEG and adapted accordingly.

02

Conditions studied

  • Development of a Tool to Assess the Level of Implementing the European Standards of Care for Newborn Health
  • Testing of the Developed Self-assessment Tool in European Hospitals
  • Self-Assessment

Keywords

  • ESCNH
  • EFCNI
  • eDlephi method
  • Pilot-testing
  • Implementation
  • Self-assessment
  • Tool
  • Neonatal care standards
03

In context

Lead sponsor

Global Foundation for the Care of Newborn Infants is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The PEG consists of 8 renowned experts of multidisciplinary professions: neonatologists, a (neonatal) nurses, an obstetrician, a parent representative, a public health expert, and a statistician and is completed by members of the EFCNI study team.

The eDelphi panels will consist of experts from various European countries from the following fields: neonatology, midwifery, (neonatal) care, obstetrics, parent representing institutions, psychology, and physiotherapy.

Participants for the pilot-testing will be healthcare professionals with varying professional backgrounds in pilot hospitals across Europe.

Eligibility criteria

Inclusion criteria Participants will be eligible if they are

  • parent representatives or representatives of caregivers of infants who received special/intensive care,
  • healthcare professionals in the field of neonatology, midwifery, neonatal nursing care, obstetrics, psychology, health sociology, physical therapy, or
  • hospital management.

Exclusion Criteria Participants will be excluded if they

  • provide insufficient proficiency of English for the eDelphi questionnaires or the languages of the self-assessment tool in the pilot testing, or
  • have a professional background that is not related to the ESCNH / individuals that are not parent representatives or representatives of caregiver of infants who received special/intensive care.
  • primarily work in the industry.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • eDelphi panel/participants

    The eDelphi panels will consist of approximately 100 healthcare professionals from various European countries from the following fields: neonatology, midwifery, (neonatal) care, obstetrics, parent representing institutions, psychology, and physiotherapy. 20-30 of them will be invited for a final consensus workshop.

    Other: Please note that this is an observational study; not applicable

  • Pilot hospitals

    10 hospitals with neonatal units from Germany, UK, France, Italy, Sweden, Portugal, and Spain.

    Other: Please note that this is an observational study; not applicable

Interventions

  • OtherPlease note that this is an observational study; not applicable

    Please note that this is an observational study; not applicable

06

What researchers measure

Primary outcomes

  1. Online self-assessment tool (including statements and questions)

    Within a two-round eDelphi survey, the eDelphi panel will critically appraise the first template of the self-assessment tool. If required (indicated by ≥ 80% of participants) additional items will be added or unnecessary items will be removed. Remaining discrepancies will be discussed in a final consensus workshop and the questionnaire will be adapted based on consensus gathered within the workshop. The resulting questionnaire will be the first version of the self-assessment tool, which will be evaluated during and adapted after a pilot-testing phase.

    Time frame: 15.06.2024 - 15.07.2025

Secondary outcomes

  1. Response rates

    Number of participants completing the first and second eDelphi round, number of hospitals joining the pilot-testing phase

    Time frame: 15.10.2024 - 30.06.2025

  2. Demographics and characteristics

    A summary of demographic information and the participants characteristics will be presented

    Time frame: 15.10.2024 - 30.06.2025

  3. User-friendliness score of the self-assessment tool

    Time taken to fill in, illustration on screen, understandability

    Time frame: 15.10.2024 - 30.06.2025

  4. Applicability score of the formulation of the questions

    Evaluation data on formulation of the questions and understandability

    Time frame: 15.10.2024 - 30.06.2025

  5. Qualitative feedback on illustration of output

    Evaluation data on illustration of questionnaire on the screen

    Time frame: 15.10.2024 - 30.06.2025

  6. Appraisal on the utilisation of the self-assessment tool

    Evaluation data on the utilisation of the self-assessment tool

    Time frame: 15.10.2024 - 30.06.2025

  7. Scalability of the self-assessment tool and dissemination

    Evaluation data on the usage and outreach

    Time frame: 15.10.2024 - 30.06.2025

07

Study locations

1 site
  • European Foundation for the Care of Newborn Infants (EFCNI)
    Munich, Bavaria 81379, Germany
08

References and documents

Publications

  • Lindacher V, Altebaeumer P, Marlow N, Matthaeus V, Straszewski IN, Thiele N, Pfeil JM, Zimmermann LJI, Mader S; European Standards of Care for Newborn Health project members. European Standards of Care for Newborn Health-A project protocol. Acta Paediatr. 2021 May;110(5):1433-1438. doi: 10.1111/apa.15712. Epub 2020 Dec 22. PubMed 33290600 ↗

Related links

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2024; primary completion for Oct 2025, 15 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 18, 2024
First posted
Apr 23, 2024
StartEst.
Jun 3, 2024
Primary completionEst.
Oct 1, 2025
CompletionEst.
Sep 1, 2026
Last update
Apr 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06379828
Lead sponsor
Global Foundation for the Care of Newborn Infants
Responsible party
Luc Zimmermann (Senior Medical Director, Global Foundation for the Care of Newborn Infants) — Principal investigator
First posted
Apr 23, 2024
Start date
Jun 3, 2024 (estimated)
Primary completion
Oct 1, 2025 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Apr 25, 2024

Study contacts

Isabel Geiger, Dr.
Contact
isabel.geiger@efcni.org
+49 (0) 89 89 0 83 26-0
Silke Mader
study director · Global Foundation for the Care of Newborn Infants
Julia Hoffmann, Dr.
study director · Global Foundation for the Care of Newborn Infants

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion